Bayer Offers $2.9B For Cancer Drugmaker Algeta
Norwegian cancer drugmaker Algeta ASA has preliminarily agreed to a takeover offer from Bayer AG after the German drug and chemical company upped its offer to value the company at almost...To view the full article, register now.
Already a subscriber? Click here to view full article